ARTICLE | Clinical News
CYT997: Development discontinued
October 1, 2012 7:00 AM UTC
YM BioSciences disclosed in its 4Q12 earnings for the year ended June 30 that it discontinued development of CYT997. The biotech said the decision is based on preclinical data of repeated low doses of...